Post-Hit®
Post-Hit®, licence 80076899: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Zollaris Laboratories Corporation
- NPN or DIN-HM
- 80076899
- Status
- Inactive licence
- Licence date
- 24 April 2017
- Revision date
- 21 October 2021
- Form
- Lotion
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Carbamide Source : Urée | 10.0 Pour cent | Not calculated |
Non-medicinal ingredients
PEG-12 diméthicone, Alcool cétéarylique, Eau, Ethylhexylglycérine, Hyaluronate de sodium, Pétrolatum, Phénoxyéthanol, Triéthanolamine, Glycérine, Vitamine E, Extrait floral de Calendula Officinalis, Stéarate de sorbitan, Poly(sorbate) 80, Huile de ricin de poly(oxyéthylène) (40), Palmitate d'éthylhexyle, Copolymère d'acrylate de sodium/Taurate d'acryloyldiméthyl sodium, Triglycéride caprylique/caprique, Glycosaminoglycanes hydrolysés
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Lotion ; maximum: 5.0 Lotion | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Protège et aide à soulager temporairement les démangeaisons et les irritations mineures cutanées. Soulage la peau sèche. Protège contre les gerçures, les rugosités et les craquelures causées par le déssèchement de la peau et les atténue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Pour un usage externe seulement. Éviter tout contact avec les yeux Consulter un praticien de soins de santé si les symptômes s'aggravent ou durent plus de 7 jours.
- Effets indésirables connus
Aucun rapport connu.
- Contre-indications
Aucun rapport connu.
Source
Official Health Canada record, licence 80076899
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.